Equal survival for Black Americans with multiple myeloma when appropriately matched to White Americans - Top-Institutions - MDSpire

Equal survival for Black Americans with multiple myeloma when appropriately matched to White Americans

  • By

  • David E. Mery

  • Guido Tricot

  • Samer Al Hadidi

  • Yihao Zhan

  • Cody Ashby

  • Clyde Bailey

  • Eric R. Siegel

  • Daisy V. Alapat

  • Hongwei Xu

  • Sandra Mattox

  • Caroline Schinke

  • Maurizio Zangari

  • Sharmilan Thanendrarajan

  • Qing Yi

  • Robert Z. Orlowski

  • Frits van Rhee

  • John D. Shaughnessy

  • Fenghuang Zhan

  • October 16, 2025

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    University of Arkansas for Medical Sciences
    University of Arkansas for Medical Sciences

    Little Rock, AR

    Key Differentiators

    • Hematology
    • Oncology
    • Transplantation

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Oncology
    • Cancer Research

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology
    • Oncology
    • Stem Cell Transplantation

  • #4

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology
    • Oncology
    • Cancer Genomics

Original Source(s)

Equal survival for Black Americans with multiple myeloma when appropriately matched to White Americans

  • by David E. Mery, Guido Tricot, Samer Al Hadidi, Yihao Zhan, Cody Ashby, Clyde Bailey, Eric R. Siegel, Daisy V. Alapat, Hongwei Xu, Sandra Mattox, Caroline Schinke, Maurizio Zangari, Sharmilan Thanendrarajan, Qing Yi, Robert Z. Orlowski, Frits van Rhee, John D. Shaughnessy, Fenghuang Zhan

  • October 16, 2025

Related Content

A single next generation sequencing assay for detection of driver mutations, rearrangements and copy number abnormalities in plasma cell dyscrasias

Bridging therapy before CAR-T for multiple myeloma: a survey from the CMWP and CTIWP of the EBMT

Evaluating Hypoalbuminemia as a Prognostic Indicator in Monoclonal Gammopathy of Undetermined Significance (MGUS) within Its Biological Framework